Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06EUM
|
|||
Former ID |
DNC012966
|
|||
Drug Name |
Rac-2-amino-5-cyclohexylpentanoic acid
|
|||
Synonyms |
5-Cyclohexylnorvaline; CHEMBL380671; 5428-12-6; NSC12805; rac-2-amino-5-cyclohexylpentanoic acid; AC1Q5S7K; AC1L5D9O; SCHEMBL5843561; 2-amino-5-cyclohexyl-valeric acid; 2-amino-5-cyclohexylpentanoic acid; NSC-12805; BDBM50179718
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H21NO2
|
|||
Canonical SMILES |
C1CCC(CC1)CCCC(C(=O)O)N
|
|||
InChI |
1S/C11H21NO2/c12-10(11(13)14)8-4-7-9-5-2-1-3-6-9/h9-10H,1-8,12H2,(H,13,14)
|
|||
InChIKey |
LGIVZSMPEFXNLH-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 5428-12-6
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1) | Target Info | Inhibitor | [1] |
KEGG Pathway | MAPK signaling pathway | |||
Cardiac muscle contraction | ||||
Adrenergic signaling in cardiomyocytes | ||||
Oxytocin signaling pathway | ||||
Hypertrophic cardiomyopathy (HCM) | ||||
Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ||||
Dilated cardiomyopathy | ||||
Panther Pathway | Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||
WikiPathways | Arrhythmogenic Right Ventricular Cardiomyopathy | |||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.